Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The ambiguity of adverse drug reactions.
Koch-Weser J, Sellers EM, Zacest R. Koch-Weser J, et al. Among authors: zacest r. Eur J Clin Pharmacol. 1977 Jan 3;11(2):75-8. doi: 10.1007/BF00562895. Eur J Clin Pharmacol. 1977. PMID: 837969
Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazine.
Reece PA, Cozamanis I, Zacest R. Reece PA, et al. Among authors: zacest r. Eur J Clin Pharmacol. 1982;23(6):523-7. doi: 10.1007/BF00637500. Eur J Clin Pharmacol. 1982. PMID: 7160421
Endralazine - a new hydralazine-like antihypertensive with high systemic bioavailability.
Reece PA, Cozamanis I, Zacest R. Reece PA, et al. Among authors: zacest r. Eur J Clin Pharmacol. 1983;25(4):553-6. doi: 10.1007/BF00542127. Eur J Clin Pharmacol. 1983. PMID: 6653651
Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasma.
Reece PA, Cozamanis I, Zacest R. Reece PA, et al. Among authors: zacest r. J Chromatogr. 1981 Sep 11;225(1):151-60. doi: 10.1016/s0378-4347(00)80254-6. J Chromatogr. 1981. PMID: 7298742
Kinetics of hydralazine and its main metabolites in slow and fast acetylators.
Reece PA, Cozamanis I, Zacest R. Reece PA, et al. Among authors: zacest r. Clin Pharmacol Ther. 1980 Dec;28(6):769-78. doi: 10.1038/clpt.1980.234. Clin Pharmacol Ther. 1980. PMID: 7438692 No abstract available.
Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteers.
Reece PA, Stafford I, Prager RH, Walker GJ, Zacest R. Reece PA, et al. Among authors: zacest r. J Pharm Sci. 1985 Feb;74(2):193-6. doi: 10.1002/jps.2600740218. J Pharm Sci. 1985. PMID: 3989691
Endralazine and sexual arousal.
Zacest R, Reece PA. Zacest R, et al. Lancet. 1983 May 28;1(8335):1221. doi: 10.1016/s0140-6736(83)92496-0. Lancet. 1983. PMID: 6134016 No abstract available.
Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man.
Reece PA, Cozamanis I, Zacest R. Reece PA, et al. Among authors: zacest r. J Chromatogr. 1980 Mar 14;181(3-4):427-40. doi: 10.1016/s0378-4347(00)81145-7. J Chromatogr. 1980. PMID: 7391156
Interference in assays for hydralazine in humans by a major plasma metabolite, hydralazine pyruvic acid hydrazone.
Reece PA, Stanley PE, Zacest R. Reece PA, et al. Among authors: zacest r. J Pharm Sci. 1978 Aug;67(8):1150-3. doi: 10.1002/jps.2600670833. J Pharm Sci. 1978. PMID: 27629
Relation of hydralazine plasma concentration to dosage and hypotensive action.
Zacest R, Koch-Weser J. Zacest R, et al. Clin Pharmacol Ther. 1972 May-Jun;13(3):420-5. doi: 10.1002/cpt1972133420. Clin Pharmacol Ther. 1972. PMID: 5026380 No abstract available.
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback